{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:40:06Z","timestamp":1791333606095,"version":"4.3.1"},"reference-count":58,"publisher":"Rockefeller University Press","issue":"3","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["APQ-0422\u20132.02\/19"],"award-info":[{"award-number":["APQ-0422\u20132.02\/19"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:p>Anti-type I interferon (IFN) autoantibodies (auto-Abs) impair antiviral immunity and have been associated with critical COVID-19. However, their prevalence and impact in Latin American populations remain incompletely delineated. This study assessed the prevalence of auto-Abs neutralizing 10 ng\/ml IFN-\u03b12 and IFN-\u03c9 in critically ill COVID-19 patients from a Brazilian cohort and their association with clinical outcomes. Among 209 patients, 14 (6.7%) tested positive, including 9.4% of deceased individuals. The proportion was 13.2% in patients older than 65 years. These individuals exhibited increased MIP-1\u03b2 levels, altered hematological parameters, and low IFN-\u03b1 levels. Survival analysis indicated shorter hospitalization survival times in auto-Ab\u2013positive patients (log-rank = 0.01). The prevalence aligns with global reports, predominantly affecting older individuals. Our findings highlight the association between type I IFN auto-Abs and worse clinical outcomes, emphasizing the need for further studies to understand their biological role and clinical implications.<\/jats:p>","DOI":"10.70962\/jhi.20250031","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T02:21:16Z","timestamp":1750213276000},"update-policy":"https:\/\/doi.org\/10.70962\/jhi.crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and association of type I IFN autoantibodies with clinical outcomes in critically ill Brazilian COVID-19 patients"],"prefix":"10.70962","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-7427","authenticated-orcid":true,"given":"Graziela P.","family":"Peduti","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00devjr72","id-type":"ROR","asserted-by":"publisher"}],"name":"Postgraduate Program in Biosciences, Federal University of S\u00e3o Francisco Valley 1 , Petrolina,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2741-150X","authenticated-orcid":true,"given":"Isadora M.","family":"Paiva","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"publisher"}],"name":"Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo 2 , Ribeir\u00e3o Preto,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-5787","authenticated-orcid":true,"given":"Adrian","family":"Gervais","sequence":"additional","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children 3 , Paris,","place":["France"]},{"name":"Imagine Institute, University Paris Cit\u00e9 4 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-354X","authenticated-orcid":true,"given":"Lorena V.","family":"Andrade","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00devjr72","id-type":"ROR","asserted-by":"publisher"}],"name":"Postgraduate Program in Biosciences, Federal University of S\u00e3o Francisco Valley 1 , Petrolina,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4029-9644","authenticated-orcid":true,"given":"Beatriz","family":"Vaconcelos","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jhswv08","id-type":"ROR","asserted-by":"publisher"}],"name":"Gon\u00e7alo Moniz Institute, Oswaldo Cruz Foundation 5 , Salvador,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-3737","authenticated-orcid":true,"given":"Pablo R.S.","family":"Oliveira","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03k3p7647","id-type":"ROR","asserted-by":"publisher"}],"name":"Biology Institute, Federal University of Bahia 6 , Salvador,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-3358","authenticated-orcid":true,"given":"Luydson R.","family":"Vasconcelos","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jhswv08","id-type":"ROR","asserted-by":"publisher"}],"name":"Aggeu Magalh\u00e3es Institute, Oswaldo Cruz Foundation 7 , Recife,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5664-4436","authenticated-orcid":true,"given":"Ricardo","family":"Khouri","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04jhswv08","id-type":"ROR","asserted-by":"publisher"}],"name":"Gon\u00e7alo Moniz Institute, Oswaldo Cruz Foundation 5 , Salvador,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1084-0065","authenticated-orcid":true,"given":"Thiago M.","family":"Cunha","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"publisher"}],"name":"Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo 2 , Ribeir\u00e3o Preto,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7995-1893","authenticated-orcid":true,"given":"Carlos D.F.","family":"Souza","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00devjr72","id-type":"ROR","asserted-by":"publisher"}],"name":"College of Medicine, Federal University of S\u00e3o Francisco Valley 8 , Petrolina,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-8922","authenticated-orcid":true,"given":"Anderson C.","family":"Armstrong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00devjr72","id-type":"ROR","asserted-by":"publisher"}],"name":"College of Medicine, Federal University of S\u00e3o Francisco Valley 8 , Petrolina,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-4169","authenticated-orcid":true,"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children 3 , Paris,","place":["France"]},{"name":"Imagine Institute, University Paris Cit\u00e9 4 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/0420db125","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University 9 , New York, NY,","place":["USA"]},{"name":"Howard Hughes Medical Institute 10 , New York, NY,","place":["USA"]},{"name":"Necker Hospital for Sick Children, Assistance Publique - H\u00f4pitaux de Paris 11 Department of Pediatrics, , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9601-6995","authenticated-orcid":true,"given":"Rodrigo F.","family":"Carmo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00devjr72","id-type":"ROR","asserted-by":"publisher"}],"name":"Postgraduate Program in Biosciences, Federal University of S\u00e3o Francisco Valley 1 , Petrolina,","place":["Brazil"]},{"id":[{"id":"https:\/\/ror.org\/00devjr72","id-type":"ROR","asserted-by":"publisher"}],"name":"College of Medicine, Federal University of S\u00e3o Francisco Valley 8 , Petrolina,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2025070809330074900_bib1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"2025070809330074900_bib2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41577-021-00656-2","article-title":"Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses\u2014are we our own worst enemy?","volume":"22","author":"Wong","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"2025070809330074900_bib3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. London. Ser. B. Biol. Sci."},{"key":"2025070809330074900_bib4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri888","article-title":"Viruses and interferon: A fight for supremacy","volume":"2","author":"Katze","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2025070809330074900_bib5","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025070809330074900_bib6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211349","article-title":"Inborn errors of tlr3-or mda5-dependent type I IFN immunity in children with enterovirus rhombencephalitis","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025070809330074900_bib7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/HEP.0000000000000701","article-title":"Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis e","volume":"79","author":"Saadat","year":"2024","journal-title":"Hepatology"},{"key":"2025070809330074900_bib8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2025070809330074900_bib9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00439-019-02108-3","article-title":"Human genetics of life-threatening influenza pneumonitis","volume":"139","author":"Zhang","year":"2020","journal-title":"Hum. Genet."},{"key":"2025070809330074900_bib10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00439-020-02127-5","article-title":"Herpes simplex virus encephalitis of childhood: Inborn errors of central nervous system cell-intrinsic immunity","volume":"139","author":"Zhang","year":"2020","journal-title":"Hum. Genet."},{"key":"2025070809330074900_bib11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/imr.13304","article-title":"Human autoantibodies neutralizing type I IFNs: From 1981 to 2023","volume":"322","author":"Bastard","year":"2024","journal-title":"Immunol. Rev."},{"key":"2025070809330074900_bib12","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci. Immunol."},{"key":"2025070809330074900_bib13","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"2025070809330074900_bib14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200413119","article-title":"The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies","volume":"119","author":"Manry","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025070809330074900_bib15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"key":"2025070809330074900_bib16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/imcb.12495","article-title":"Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19","volume":"99","author":"Abers","year":"2021","journal-title":"Immunol. Cell Biol."},{"key":"2025070809330074900_bib17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10875-022-01252-2","article-title":"Early and rapid identification of COVID-19 patients with neutralizing type I interferon auto-antibodies","volume":"42","author":"Akbil","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13613-022-01095-5","article-title":"Auto-antibodies against type I IFNs in &gt; 10% of critically ill COVID-19 patients: A prospective multicentre study","volume":"12","author":"Arrestier","year":"2022","journal-title":"Ann. Intensive Care"},{"key":"2025070809330074900_bib19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210554","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025070809330074900_bib20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001709","article-title":"Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease","volume":"20","author":"Busnadiego","year":"2022","journal-title":"PLoS Biol."},{"key":"2025070809330074900_bib21","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat. Commun."},{"key":"2025070809330074900_bib22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10875-021-01203-3","article-title":"Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital","volume":"42","author":"Chauvineau-Grenier","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib23","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s10875-022-01308-3","article-title":"Neutralizing type I interferon autoantibodies in Japanese patients with severe COVID-19","volume":"42","author":"Eto","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib24","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1327","article-title":"Antibodies against type I interferon: Detection and association with severe clinical outcome in COVID-19 patients","volume":"10","author":"Goncalves","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"2025070809330074900_bib25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00134-021-06392-4","article-title":"Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients","volume":"47","author":"Koning","year":"2021","journal-title":"Intensive Care Med."},{"key":"2025070809330074900_bib26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1","volume":"131","author":"Meisel","year":"2021","journal-title":"J. Clin. Invest."},{"key":"2025070809330074900_bib27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10875-023-01512-9","article-title":"Autoantibodies neutralizing type I IFNs in the bronchoalveolar lavage of at least 10% of patients during life-threatening COVID-19 pneumonia","volume":"43","author":"Philippot","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s10875-021-01136-x","article-title":"Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in barcelona","volume":"41","author":"Solanich","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib29","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s10875-021-01036-0","article-title":"Neutralizing autoantibodies to type I IFNs in &gt;10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain","volume":"41","author":"Troya","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"2025070809330074900_bib31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2025070809330074900_bib32","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","article-title":"Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19","volume":"184","author":"Ziegler","year":"2021","journal-title":"Cell"},{"key":"2025070809330074900_bib33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj7521","article-title":"Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort","volume":"14","author":"Carapito","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"2025070809330074900_bib34","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/eji.202249824","article-title":"Anti-IFN-\u03b1\/-\u03c9 neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity","volume":"52","author":"Frasca","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"2025070809330074900_bib35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s10875-021-01168-3","article-title":"Interferon-\u03b12 auto-antibodies in convalescent plasma therapy for COVID-19","volume":"42","author":"Raadsen","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib36","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01280-22","article-title":"Increased presence of antibodies against type I interferons and human endogenous retrovirus W in intensive care unit COVID-19 patients","volume":"10","author":"Simula","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"2025070809330074900_bib37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12964-022-00903-6","article-title":"A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients","volume":"20","author":"Soltani-Zangbar","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"2025070809330074900_bib38","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3390\/v13122553","article-title":"Microarray-based detection of antibodies against sars-cov-2 proteins, common respiratory viruses and type i interferons","volume":"13","author":"Savvateeva","year":"2021","journal-title":"Viruses"},{"key":"2025070809330074900_bib39","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41551-022-00925-y","article-title":"Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries","volume":"6","author":"Credle","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"2025070809330074900_bib40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/jir.2023.0003","article-title":"Autoantibodies neutralizing type III interferons are uncommon in patients with severe coronavirus disease 2019 pneumonia","volume":"43","author":"Vanker","year":"2023","journal-title":"J. Interferon Cytokine Res."},{"key":"2025070809330074900_bib41","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29089","article-title":"Examination of autoantibodies to type I interferon in patients suffering from long COVID","volume":"95","author":"Hansen","year":"2023","journal-title":"J. Med. Virol."},{"key":"2025070809330074900_bib42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"2025070809330074900_bib43","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10875-022-01325-2","article-title":"Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization","volume":"42","author":"Lamacchia","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.20411\/pai.v7i2.537","article-title":"Immune dysregulation in acute SARS-CoV-2 infection","volume":"7","author":"Grimm","year":"2022","journal-title":"Pathog. Immun."},{"key":"2025070809330074900_bib45","doi-asserted-by":"publisher","first-page":"17344","DOI":"10.1038\/s41598-023-43675-w","article-title":"Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons","volume":"13","author":"Saheb Sharif-Askari","year":"2023","journal-title":"Sci. Rep."},{"key":"2025070809330074900_bib46","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10875-021-01060-0","article-title":"Neutralizing autoantibodies to type I interferons in COVID-19 convalescent donor plasma","volume":"41","author":"Vazquez","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025070809330074900_bib47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","article-title":"Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis","volume":"148","author":"Lemarquis","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025070809330074900_bib48","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.jaut.2021.102598","article-title":"COVID-19 convalescent plasma composition and immunological effects in severe patients","volume":"118","author":"Acosta-Ampudia","year":"2021","journal-title":"J. Autoimmun."},{"key":"2025070809330074900_bib49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/jir.2023.0087","article-title":"High anti-interferon-alpha autoantibody levels in severe\/critical COVID-19 patients from Peru","volume":"43","author":"Pons","year":"2023","journal-title":"J. Interf. Cytokine Res."},{"key":"2025070809330074900_bib50","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1073\/pnas.1504447112","article-title":"Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations","volume":"112","author":"Kehdy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025070809330074900_bib51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","article-title":"Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985\u20132014","volume":"79","author":"Myasoedova","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"2025070809330074900_bib52","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1158\/1055-9965.epi-14-0429","article-title":"Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women","volume":"23","author":"Parks","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2025070809330074900_bib53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211211","article-title":"Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs","volume":"218","author":"Lopez","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025070809330074900_bib54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): An overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"key":"2025070809330074900_bib55","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of covid-19 and influenza highlights the role of type i interferons in development of severe covid-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"2025070809330074900_bib56","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"key":"2025070809330074900_bib57","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3390\/microorganisms9112259","article-title":"Elevated Anti-SARS-CoV-2 antibodies and IL-6, IL-8, MIP-1\u03b2, early predictors of severe COVID-19","volume":"9","author":"Codina","year":"2021","journal-title":"Microorganisms"},{"key":"2025070809330074900_bib58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of Human Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250031\/1946907\/jhi_20250031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250031\/1946907\/jhi_20250031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T09:33:09Z","timestamp":1751967189000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jhi\/article\/1\/3\/e20250031\/278104\/Prevalence-and-association-of-type-I-IFN"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.70962\/jhi.20250031","relation":{},"ISSN":["3065-8993"],"issn-type":[{"value":"3065-8993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"article-number":"e20250031"}}